Industrial hemp is an annual herbaceous plant in the Cannabaceae family. It is distinguished from psychoactive marijuana by its THC (tetrahydrocannabinol) content of <0.3% and is legally defined in many countries, offering significant development potential.
Core Advantages.
1.High-value components: Rich in cannabidiol (CBD), which has medical applications such as anti-epileptic and anti-inflammatory effects. The global CBD market is projected to reach $36.6 billion by 2033. Additional components like CBG and CBN also hold untapped potential.
2.Diverse applications: Used in pharmaceuticals for disease treatment; rapidly penetrating consumer markets such as food, cosmetics, and e-cigarettes; and serving as eco-friendly industrial fiber materials or seed oil substitutes for petrochemicals.
3.Policy support: Relaxed regulations by the United Nations, coupled with legalization efforts in the U.S., France, and other countries, provide a favorable policy environment.
Production Technology
Cultivation in controlled environments: Plant factories enhance CBD content by 30–50%, reduce land use, and ensure stable yields. However, challenges include limited specialized cultivars, high technical/energy costs, and underdeveloped equipment.
Extraction methods:
1.Supercritical CO₂: High purity but patent-restricted.
2.Solvent extraction: Low-cost but being phased out due to stricter purity regulations.
3.Emerging technologies (e.g., molecular distillation) are under exploration.
Market Landscape
Global production hubs include North America, the EU, and China. In China, legal cultivation is restricted to Yunnan and Heilongjiang provinces, which contribute 50% of global output. However, China relies on imported high-CBD cultivars. Licensing is limited, resulting in oligopolistic processing/production by a few dominant firms. Some companies are expanding overseas to circumvent domestic policy constraints.
Challenges and Trends
1.Challenges: Dependence on imported technology, policy fragmentation, and inconsistent product quality.
2.Trends: Adoption of AI and synthetic biology for innovation; industry expansion into high-value end products; policy liberalization in Asia-Pacific creating new opportunities.